## Abstract In this study we investigated the relationship between binding of anti‐tumor antibodies by polyoma‐virus‐induced SEYF‐a tumor cells and the expression of immune‐complex receptors on these cells. It was shown that in vivo propagated cells became progressively coated with IgG. The increas
Tumor-bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic anti-tumor antibodies
✍ Scribed by Maya Ran; Isaac P. Witz; George Klein
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- French
- Weight
- 679 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The experiments described herein were designed to determine whether part of the Ig coat of tumor cells consists of specific anti‐tumor antibodies. It was demonstrated that the inoculation of polyoma virus‐induced sarcoma cells (SEYF‐a) into syngeneic A.B Y mice stimulates the production of cytotoxic antibodies against the tumor‐cell population. The level of these antibodies, which was undetectable during the first week after transplantation, increased markedly during the second week, and remained high thereafter. Following the increase in cytotoxic antibodies in the serum, a cell‐bound potentially cytotoxic antibody was detected on the tumor cells by testing their sensitivity to rabbit complement. The increase in cell‐bound, potentially cytotoxic antibody followed the kinetics of the increase in serum antibody during the second week after transplantation and was inversely correlated to the amount of free antigens on the cell surface. These antigens, responsible for the sensitivity of the cells to a syngeneic hyperimmune cytotoxic antiserum, became non‐available for the cytotoxic antibodies during propagation of the tumor cells. Cells from a tumor propagated for 3 weeks could not compete for antitumor antibodies with cells propagated for 1 week. Yet it was possible to increases the antigenic capacity of cells from an old tumor by a treatment that would cause the release of tumor‐associated Ig. Cytotoxic anti‐SEYF‐a antibodies could be dissociated from tumor cells propagated in vivo by methods causing dissociation of antigen‐antibody complexes, and detected in tumor eluates.
📜 SIMILAR VOLUMES
## Abstract Immunoglobulin (Ig) “coating” on different in vivo growing mouse tumors was investigated using several approaches. Radioiodine‐labelled purified protein A from Staphylococcus aureus, a specific ragent for Fc of IgG, and/or iodinated pruified antibodies against mouse immunoglobulins, wer
## Participation of a dominant cytotoxic T cell population defined by a monoclonal antibody in syngeneic anti-tumor responses* Cytotoxic T lymphocyte (CTL) clones against a syngeneic Friend virus-induced erythroleukemia (FBL-3) were generated in C57BL/6 (B6) mice. A monoclonal antibody (mAb, N9-12
The effects of combining estramustine (EM) with vinblastine (VLB) or doxorubicin (DOX) on cellular uptake, cellular retention and cell survival were investigated in Dunning horrnoneinsensitive rat prostate AT-I tumor cells and DU-145 human prostatic tumor cells. Accumulation of VLB and DOX by AT-I c
The anti-tumor effects of actinomycin D (Act D) and recombinant human tumor necrosis factor (TNF)-a have been studied on 4 established murine tumor cell lines: MmBI6 melanoma, Lewis lung (LL/2) carcinoma, L I sarcoma and L I 2 10 leukemia. During short-term incubation (24 hr) Act D produced dosedepe
## Interleukin -2-activated, cultured NK cells (A-NK) cells were adoptively transferred into a syngeneic rat liver-tumor model. The kinetics of tumor infiltration by NK cells, originating either from adoptively transferred or from endogenous sources, the localization of these cells in the tumor, a